Michael J. Parnham
Impact in
- Toxicology top 1%
- Organoselenium and organotellurium chemistry
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
Papers in
- Pharmacology 42
- Inflammatory mediators and NSAID effects 32
- Pharmacogenetics and Drug Metabolism 7
- Co-authors
- I.L. Bonta (22 shared papers)Vesna Eraković Haber (8 shared papers)Andreas von Knethen (7 shared papers)Helmut Sies (1 shared paper)Bernhard Brüne (4 shared papers)Gerd Geißlinger (30 shared papers)Ognjen Čulić (4 shared papers)Gianpaolo Perletti (1 shared paper)
- Journals
- Inflammation Research (14 papers)International Journal of Molecular Sciences (8 papers)European Journal of Pharmacology (5 papers)Prostaglandins (4 papers)Expert Opinion on Investigational Drugs (4 papers)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Michael J. Parnham
153 papers receiving 4.4k citations
Michael J. Parnham's Hit Papers
Peers
Comparison fields: 5 of 160
- Toxicology 175
- Pharmacology 686
- Biochemistry 252
- Pharmacology 239
- Immunology 481
Countries citing papers authored by Michael J. Parnham
This map shows the geographic impact of Michael J. Parnham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Parnham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Parnham more than expected).
Fields of papers citing papers by Michael J. Parnham
This network shows the impact of papers produced by Michael J. Parnham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Parnham. The network helps show where Michael J. Parnham may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael J. Parnham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nrf2, the Master Regulator of Anti-Oxidative Responses Hit paper breakdown → | 2017 | 575 |
| 2 | Azithromycin: Mechanisms of action and their relevance for clinical applications Hit paper breakdown → | 2014 | 459 |
| 3 | 2001 | 263 | |
| 4 | 2000 | 243 | |
| 5 | 2005 | 125 | |
| 6 | 2020 | 119 | |
| 7 | 1978 | 111 | |
| 8 | 1988 | 111 | |
| 9 | 1993 | 109 | |
| 10 | 2012 | 100 | |
| 11 | 1996 | 92 | |
| 12 | 2005 | 82 | |
| 13 | 2005 | 79 | |
| 14 | 2007 | 78 | |
| 15 | 2009 | 73 | |
| 16 | 1982 | 70 | |
| 17 | 2015 | 67 | |
| 18 | 2011 | 60 | |
| 19 | 2013 | 58 | |
| 20 | 1983 | 57 |
About Michael J. Parnham
Michael J. Parnham is a scholar working on Pharmacology, Molecular Biology, Physiology, Immunology and Pulmonary and Respiratory Medicine, having authored 159 papers that have together received 4.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (32 papers), Asthma and respiratory diseases (16 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Immune Response and Inflammation (9 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Cytokine Signaling Pathways and Interactions (7 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Estrogen and related hormone effects (7 papers). The work is most often cited by research in Toxicology (175 citations), Pharmacology (686 citations), Biochemistry (252 citations), Pharmacology (239 citations) and Immunology (481 citations). Michael J. Parnham has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include I.L. Bonta, Vesna Eraković Haber, Andreas von Knethen, Helmut Sies, Bernhard Brüne, Gerd Geißlinger, Ognjen Čulić, Gianpaolo Perletti, Robin Vos and Evangelos J. Giamarellos‐Bourboulis. Their work appears in journals such as Inflammation Research, International Journal of Molecular Sciences, European Journal of Pharmacology, Prostaglandins and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.